# Neurocrine Biosciences, Inc. (NBIX) Neurocrine Biosciences (NBIX) faces a stock dip due to missed EPS and a failed study, despite strong INGREZZA sales. Analysts remain cautiously optimistic with some lowering price targets. ### About Neurocrine Biosciences, Inc. Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on treatments for neurological and endocrine-related disorders. Neurocrine Biosciences, Inc. uses the ticker $NBIX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors. ### Insights - Neurocrine Biosciences, Inc. (NBIX) market dominance near a 52-week low at [-------]. - Neurocrine Biosciences, Inc. (NBIX) trading volume is up 66.03% from the previous week. - Neurocrine Biosciences, Inc. (NBIX) Galaxy Score™ is up 112% from the previous month. - Neurocrine Biosciences, Inc. (NBIX) sentiment is up 44.93% from the previous week. - Neurocrine Biosciences, Inc. (NBIX) creators is up 55% from the previous week. - Neurocrine Biosciences, Inc. (NBIX) engagements is up 116.04% from the previous month. - Neurocrine Biosciences, Inc. (NBIX) mentions is up 97.11% from the previous week. - Neurocrine Biosciences, Inc. entered the top [--] AltRank™ for the first time ### Price: $128.40  [Price 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/close.tsv) The stock price experienced a minor dip of -1.92% in the last [--] hours, primarily due to missed EPS estimates and the failure of the KINECT-DCP study, despite strong INGREZZA sales and positive analyst sentiment. 24-Hour: 0.49% 7-Day: -3.11% 30-Day: -4.58% 1-Year High: $155.60 on 2025-12-10 1-Year Low: $87.50 on 2025-04-08 ### AltRank: [---]  [AltRank 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/alt_rank.tsv) Neurocrine Biosciences, Inc. (NBIX) is currently AltRank #399 based on combined combined social and market metrics Daily Average: [---] [--] Week: [-----] +816 [--] Month: [-----] +396 [--] Months: [-----] +346 [--] Year: [-----] [----] 1-Year High: [-----] on 2026-02-01 1-Year Low: [--] on 2025-07-12 ### Galaxy Score: [-----]  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/galaxy_score.tsv) Current Value: [-----] Daily Average: [--] [--] Week: [--] +8 [--] Month: [--] +28 [--] Months: [--] [---] [--] Year: [--] [---] 1-Year High: [--] on 2025-07-02 1-Year Low: [--] on 2025-09-24 ### Engagements: [-----] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/interactions.tsv) Current Value: [-----] Daily Average: [-----] [--] Week: [-------] +41% [--] Month: [-------] +116% [--] Months: [---------] -57% [--] Year: [---------] -3.10% 1-Year High: [-------] on 2025-05-05 1-Year Low: [---] on 2026-02-01 Engagements by network (24h): News: [--] Reddit: [--] X: [-----] TikTok: [--] YouTube: [--] ### Mentions: [--] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/posts_active.tsv) Current Value: [--] Daily Average: [---] [--] Week: [---] +97% [--] Month: [---] +19% [--] Months: [-----] -86% [--] Year: [------] +259% 1-Year High: [-----] on 2025-07-03 1-Year Low: [--] on 2025-12-07 Mentions by network (24h): News: [--] Reddit: [--] X: [--] TikTok: [--] YouTube: [--] ### Creators: [--] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/contributors_active.tsv) [--] unique social accounts have posts mentioning Neurocrine Biosciences, Inc. (NBIX) in the last [--] hours which is down 14% from [--] in the previous [--] hours Daily Average: [---] [--] Week: [---] +55% [--] Month: [---] -9.20% [--] Months: [---] -93% [--] Year: [------] +701% 1-Year High: [-----] on 2025-07-03 1-Year Low: [--] on 2025-12-07 The most influential creators that mention Neurocrine Biosciences, Inc. in the last [--] hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@Andre_AGTC](/creator/twitter/Andre_AGTC) | [--] | [-----] | [--] | [---] | | [@MarcJacksonLA](/creator/twitter/MarcJacksonLA) | [--] | [-----] | [--] | [---] | | [@doepke_michel](/creator/twitter/doepke_michel) | [--] | [-----] | [--] | [---] | | [@OracleEarnings](/creator/twitter/OracleEarnings) | [--] | [------] | [--] | [---] | | [@AIStockSavvy](/creator/twitter/AIStockSavvy) | [--] | [------] | [--] | [--] | | [@Pharmdca](/creator/twitter/Pharmdca) | [--] | [-------] | [--] | [--] | | [@moneyforfun_](/creator/twitter/moneyforfun_) | [--] | [-----] | [--] | [--] | | [@OpenOutcrier](/creator/twitter/OpenOutcrier) | [--] | [----------] | [--] | [--] | | [@neurocrinebiosciencesinc](/creator/youtube/neurocrinebiosciencesinc) | [--] | [--] | [--] | [--] | [View More](/list/creators/neurocrine-biosciences-inc/100) ### Sentiment: 85%  [Sentiment 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/sentiment.tsv) Current Value: 85% Daily Average: 67% [--] Week: 100% +31% [--] Month: 79% -4% [--] Months: 79% no change [--] Year: 79% +25% 1-Year High: 100% on 2025-07-20 1-Year Low: 25% on 2025-09-15 Most Supportive Themes: - Ingrezza Sales Growth: (40%) Ingrezza sales are increasing market penetration and revenue. - Crenessity Phase [--] Study: (35%) Positive outcomes from the Crenessity Phase [--] study boost confidence in Neurocrine's pipeline. - Affordable Growth Potential: (25%) Mentions in 'Affordable Growth' screens highlight the potential for long-term value. Most Critical Themes: - Missed EPS Estimates: (5%) Missed EPS estimates may cause short-term volatility. ### Social Dominance: 0.00455%  [Social Dominance 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/social_dominance.tsv) Current Value: 0.00455% Daily Average: 0.02% [--] Week: 0.00407% -0.018% [--] Month: 0.0066% +0.002% [--] Months: 0.0066% -0.014% [--] Year: 0.0066% -0.031% 1-Year High: 0.211% on 2025-07-03 1-Year Low: 0.0021% on 2025-12-07 ### Market Dominance: 0.015%  [Market Dominance 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/market_dominance.tsv) Current Value: 0.015% Daily Average: 0% 1-Year High: 0.389% on 2025-04-09 1-Year Low: 0.014% on 2026-02-12 ### Market Cap: $12,884,661,380  [Market Cap 24-Hour Time-Series Raw Data](/topic/neurocrine-biosciences-inc/time-series/market_cap.tsv) Current Value: $12,884,661,380 Daily Average: $13,021,887,182 [--] Week: $12,884,661,380 -0.76% [--] Month: $12,884,661,380 -2.40% [--] Months: $12,884,661,380 -4.10% [--] Year: $12,884,661,380 +13% 1-Year High: $15,517,197,780 on 2025-12-10 1-Year Low: $8,990,517,324 on 2025-04-12 ### Top Neurocrine Biosciences, Inc. Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "$MU -Needham raises Micron target to $450 from $380 Buy - $NBIX -JPMorgan lowers Neurocrine Biosciences target to $176 from $177 Overweight -Truist lowers target to $140 from $169 Buy - $NMRA -William Blair upgrades Neumora Therapeutics to Outperform from Market Perform -" [X Link](https://x.com/MarcJacksonLA/status/2023970380017209579) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2026-02-18T03:58Z [----] followers, [---] engagements "End of [----] update Top 10+15 $MDGL NASH $KRYS DEB $AXSM MDD ADA $XENE FOS $RVMD RASmuti $PRAX ET $ABVX IBD $BBIO ATTR $MIRM IBAT $CTYK oHCM $CRNX $SRRK $NKTR $NUVL $VKTX $IMVT $VTYX $CYBN $ABEO $BLTE $CPRX $ALNY $MLYS $VRDN $KYMR Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY RNAi $CPRX $ABEO $CORT $KYMR $NUVL $QURE $IMCR $NBIX $VKTX $MLYS Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY" [X Link](https://x.com/Andre_AGTC/status/2006437257927078374) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-12-31T18:48Z [----] followers, 18K engagements "Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY RNAi $CPRX $ABEO $CORT $KYMR $NUVL $QURE $IMCR $NBIX $VKTX $MLYS Update top 10+10 (after $VRNA BO) $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $VKTX metabolic $MIRM IBAT rare $MLTX I&I IL17A/F $SRRK TGFb $ALNY RNAi $RVMD RASmuti $BBIO $CRNX $CPRX $ABEO $KYMR $NUVL $IMCR $ACAD $CORT $NBIX Update top 10+10 (after $VRNA BO) $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $VKTX metabolic $MIRM IBAT rare $MLTX I&I IL17A/F $SRRK" [X Link](https://x.com/Andre_AGTC/status/1973033636619555030) [@Andre_AGTC](/creator/x/Andre_AGTC) 2025-09-30T14:34Z [----] followers, 37.2K engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
Neurocrine Biosciences (NBIX) faces a stock dip due to missed EPS and a failed study, despite strong INGREZZA sales. Analysts remain cautiously optimistic with some lowering price targets.
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on treatments for neurological and endocrine-related disorders.
Neurocrine Biosciences, Inc. uses the ticker $NBIX for trading. Listed in the Stocks category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
The stock price experienced a minor dip of -1.92% in the last [--] hours, primarily due to missed EPS estimates and the failure of the KINECT-DCP study, despite strong INGREZZA sales and positive analyst sentiment.
24-Hour: 0.49% 7-Day: -3.11% 30-Day: -4.58%
1-Year High: $155.60 on 2025-12-10
1-Year Low: $87.50 on 2025-04-08
AltRank 24-Hour Time-Series Raw Data
Neurocrine Biosciences, Inc. (NBIX) is currently AltRank #399 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [-----] +816
[--] Month: [-----] +396
[--] Months: [-----] +346
[--] Year: [-----] [----]
1-Year High: [-----] on 2026-02-01
1-Year Low: [--] on 2025-07-12
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +8
[--] Month: [--] +28
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-07-02
1-Year Low: [--] on 2025-09-24
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [-------] +41%
[--] Month: [-------] +116%
[--] Months: [---------] -57%
[--] Year: [---------] -3.10%
1-Year High: [-------] on 2025-05-05
1-Year Low: [---] on 2026-02-01
Engagements by network (24h): News: [--] Reddit: [--] X: [-----] TikTok: [--] YouTube: [--]
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [---]
[--] Week: [---] +97%
[--] Month: [---] +19%
[--] Months: [-----] -86%
[--] Year: [------] +259%
1-Year High: [-----] on 2025-07-03
1-Year Low: [--] on 2025-12-07
Mentions by network (24h): News: [--] Reddit: [--] X: [--] TikTok: [--] YouTube: [--]
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Neurocrine Biosciences, Inc. (NBIX) in the last [--] hours which is down 14% from [--] in the previous [--] hours
Daily Average: [---]
[--] Week: [---] +55%
[--] Month: [---] -9.20%
[--] Months: [---] -93%
[--] Year: [------] +701%
1-Year High: [-----] on 2025-07-03
1-Year Low: [--] on 2025-12-07
The most influential creators that mention Neurocrine Biosciences, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Andre_AGTC | [--] | [-----] | [--] | [---] |
| @MarcJacksonLA | [--] | [-----] | [--] | [---] |
| @doepke_michel | [--] | [-----] | [--] | [---] |
| @OracleEarnings | [--] | [------] | [--] | [---] |
| @AIStockSavvy | [--] | [------] | [--] | [--] |
| @Pharmdca | [--] | [-------] | [--] | [--] |
| @moneyforfun_ | [--] | [-----] | [--] | [--] |
| @OpenOutcrier | [--] | [----------] | [--] | [--] |
| @neurocrinebiosciencesinc | [--] | [--] | [--] | [--] |
Sentiment 24-Hour Time-Series Raw Data
Current Value: 85%
Daily Average: 67%
[--] Week: 100% +31%
[--] Month: 79% -4%
[--] Months: 79% no change
[--] Year: 79% +25%
1-Year High: 100% on 2025-07-20
1-Year Low: 25% on 2025-09-15
Most Supportive Themes:
Most Critical Themes:
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00455%
Daily Average: 0.02%
[--] Week: 0.00407% -0.018%
[--] Month: 0.0066% +0.002%
[--] Months: 0.0066% -0.014%
[--] Year: 0.0066% -0.031%
1-Year High: 0.211% on 2025-07-03
1-Year Low: 0.0021% on 2025-12-07
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.015%
Daily Average: 0%
1-Year High: 0.389% on 2025-04-09
1-Year Low: 0.014% on 2026-02-12
Market Cap 24-Hour Time-Series Raw Data
Current Value: $12,884,661,380
Daily Average: $13,021,887,182
[--] Week: $12,884,661,380 -0.76%
[--] Month: $12,884,661,380 -2.40%
[--] Months: $12,884,661,380 -4.10%
[--] Year: $12,884,661,380 +13%
1-Year High: $15,517,197,780 on 2025-12-10
1-Year Low: $8,990,517,324 on 2025-04-12
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"$MU -Needham raises Micron target to $450 from $380 Buy - $NBIX -JPMorgan lowers Neurocrine Biosciences target to $176 from $177 Overweight -Truist lowers target to $140 from $169 Buy - $NMRA -William Blair upgrades Neumora Therapeutics to Outperform from Market Perform -"
X Link @MarcJacksonLA 2026-02-18T03:58Z [----] followers, [---] engagements
"End of [----] update Top 10+15 $MDGL NASH $KRYS DEB $AXSM MDD ADA $XENE FOS $RVMD RASmuti $PRAX ET $ABVX IBD $BBIO ATTR $MIRM IBAT $CTYK oHCM $CRNX $SRRK $NKTR $NUVL $VKTX $IMVT $VTYX $CYBN $ABEO $BLTE $CPRX $ALNY $MLYS $VRDN $KYMR Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY RNAi $CPRX $ABEO $CORT $KYMR $NUVL $QURE $IMCR $NBIX $VKTX $MLYS Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY"
X Link @Andre_AGTC 2025-12-31T18:48Z [----] followers, 18K engagements
"Q4 Update top 10+10 $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $MIRM IBAT rare $RVMD RASmuti $CRNX endocrine $BBIO ATTR $SRRK TGFb $ALNY RNAi $CPRX $ABEO $CORT $KYMR $NUVL $QURE $IMCR $NBIX $VKTX $MLYS Update top 10+10 (after $VRNA BO) $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $VKTX metabolic $MIRM IBAT rare $MLTX I&I IL17A/F $SRRK TGFb $ALNY RNAi $RVMD RASmuti $BBIO $CRNX $CPRX $ABEO $KYMR $NUVL $IMCR $ACAD $CORT $NBIX Update top 10+10 (after $VRNA BO) $MDGL NASH $AXSM CNS MDD $XENE CNS seizures $KRYS GT DEB $VKTX metabolic $MIRM IBAT rare $MLTX I&I IL17A/F $SRRK"
X Link @Andre_AGTC 2025-09-30T14:34Z [----] followers, 37.2K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/neurocrine-biosciences-inc